NDC 51662-1442

VERAPAMIL HCI

Verapamil Hci

VERAPAMIL HCI is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Verapamil Hydrochloride.

• Product ID: 51662-1442_9a4f12ec-fe1d-a1b9-e053-2a95a90ac8e4
• NDC: 51662-1442
• Product Type: Human Prescription Drug
• Proprietary Name: VERAPAMIL HCI
• Generic Name: Verapamil Hci
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-12-22
• Marketing Category: NDA / NDA
• Application Number: NDA018925
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: VERAPAMIL HYDROCHLORIDE
• Active Ingredient Strength: 3 mg/mL
• Pharm Classes: P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1442-1

2 mL in 1 VIAL (51662-1442-1)

• Marketing Start Date: 2019-12-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1442-1 [51662144201]

VERAPAMIL HCI INJECTION

• Marketing Category: NDA
• Application Number: NDA018925
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-12-22

Drug Details

Active Ingredients

Ingredient	Strength
VERAPAMIL HYDROCHLORIDE	2.5 mg/mL

Pharmacological Class

• P-Glycoprotein Inhibitors [MoA]
• Calcium Channel Antagonists [MoA]
• Calcium Channel Blocker [EPC]
• Cytochrome P450 3A4 Inhibitors [MoA]
• Cytochrome P450 3A Inhibitors [MoA]

NDC Crossover Matching brand name "VERAPAMIL HCI" or generic name "Verapamil Hci"

NDC	Brand Name	Generic Name
51662-1269	VERAPAMIL HCI	VERAPAMIL HCI
51662-1442	VERAPAMIL HCI	VERAPAMIL HCI
51662-1548	VERAPAMIL HCI	VERAPAMIL HCI